Brief: Medicinova Receives Notice Of Decision To Grant For New Patent Covering Mn-166 (Ibudilast) For Treatment Of Progressive Multiple Sclerosis
06/12/2023 23:08
Dec 6 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA RECEIVES A NOTICE OF DECISION TO GRANT FOR A
NEW
PATENT COVERING MN-166 (IBUDILAST) FOR THE TREATMENT OF
PROGRESSIVE MS IN EUROPE
Source text for Eikon: ID:nGNXbvrslQ
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake